A new set of Investor Relations (IR) questions and responses from biotechs provided by Mike O'Neill has been posted, covering financials and upcoming catalysts for each biotech stock. These posts provide a great starting point for your due diligence research on each of these stocks. Answers are either provided directly by company executives or are summarized based on Mike's research.
This round of responses features PTIE Pain Therapeutics, ONCY Oncolytics Biotech, RIGL Rigel Pharma, INSV InSite Vision, and SNTI Senesco Technologies.
Check out the complete index of all IR Questions and Answers if you missed any of the previous editions - now covering dozens of biotech and pharmaceutical companies!